Preferred Label : caplacizumab;

CISMeF synonym : ALX-0081;

Related MeSH term : caplacizumab-yhdp;

Is substance : O;

UNII : 2R27AB6766;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-marr/caplacizumab
2023
false
false
false
France
French
popular works
risk management
continuity of patient care
hemorrhage
caplacizumab
caplacizumab

---
https://www.has-sante.fr/jcms/p_3295753/fr/cablivi-10-mg-caplacizumab
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
caplacizumab
injections, subcutaneous
injections, intravenous
adult
caplacizumab
thrombotic thrombocytopenic purpura, acquired
drug therapy, combination
evaluation of the transparency committee

---
https://www.has-sante.fr/portail/jcms/c_2964765/fr/cablivi
2019
false
false
false
France
French
caplacizumab
orphan drug production
adult
thrombotic thrombocytopenic purpura, acquired
injections, intravenous
injections, subcutaneous
von willebrand factor
treatment outcome
evaluation of the transparency committee
caplacizumab
Single-Domain antibodies
purpura, thrombotic thrombocytopenic

---
https://www.ema.europa.eu/medicines/human/EPAR/Cablivi
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
caplacizumab
drug approval
europe
caplacizumab
orphan drug production
product surveillance, postmarketing
adult
thrombotic thrombocytopenic purpura, acquired
injections, intravenous
injections, subcutaneous
von willebrand factor
pregnancy
breast feeding
drug evaluation, preclinical
Single-Domain antibodies
caplacizumab
Single-Domain antibodies
purpura, thrombotic thrombocytopenic

---
Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.